Home › VascularLive

Module 3: Metanx® Clinical Evidence

You must be registered and logged in to view this presentation. Registration is free. Click here to register or here to login if already a member of CathLabLive.com. You may view a preview of this presentation below.

Allen Jacobs, DPM, FAPWCA, FACFAS

Private Practice

View other Segments:
Module 1: Diabetic Neuropathy Epidemiology	View
Module 2: Epidermal Nerve Fiber Density Overview	View
Module 4: Clinical Case Presentation #1	View
Module 5: Clinical Case Presentation #2	View
Module 6: Clinical Implications	View

+ Featured Presentations

Attaining Success with IVC Filters
Peripheral CTA for the diagnosis of PVD
Module 6: Clinical Implications
Module 5: Clinical Case Presentation #2
Module 4: Clinical Case Presentation #1
Module 2: Epidermal Nerve Fiber Density Overview
Module 1: Diabetic Neuropathy Epidemiology

+ Discussion

Presented By:

Module 3: Metanx® Clinical Evidence

Dr. Allen Jacobs provides an overview of progressive symptomatic diabetic peripheral neuropathy, including diagnostic tools and symptomatic vs. disease modifying agents. He presents successful clinical outcomes of improving epidermal nerve fiber densities with a neurotrophic agent.

REQUEST INFORMATION
SPONSOR WEBSITE
FORWARD TO colleague
ADD THIS / SHARE THIS

Module 3: Metanx® Clinical Evidence

+ Featured Presentations

+ Discussion

+ Login to Post a New Topic

Module 3: Metanx® Clinical Evidence